SCM
TERN

Silverarc Capital Management’s Terns Pharmaceuticals TERN Stock Holding History

Silverarc Capital Management’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-250,551
Closed -$1.64M – 88
2024
Q1 		$1.64M Sell
250,551
-266,448
-52% -$1.74M 0.46% 53
2023
Q4 		$3.36M Buy
516,999
+16,999
+3% +$89.9K 1.03% 37
2023
Q3 		$2.52M Sell
500,000
-99,668
-17% -$632K 0.94% 42
2023
Q2 		$5.25M Sell
599,668
-68,254
-10% -$796K 1.77% 21
2023
Q1 		$7.91M Sell
667,922
-32,078
-5% -$307K 3.55% 6
2022
Q4 		$7.13M Buy
700,000
+685,527
+4,737% +$4.56M 2.45% 18
2022
Q3 		$85K Buy
+14,473
New +$53.8K 0.04% 76

Other funds holding TERN

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return